Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The history shows a new revision entry, v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record history metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-05T20:20:40.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, was added to the record history, and the prior revision, v3.5.3, was removed from the list.
    Difference
    0.1%
    Check dated 2026-05-15T09:42:30.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page’s UI/documentation footer revision number was updated from v3.5.2 to v3.5.3, indicating a minor system or display update rather than a change to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the version history.
    Difference
    0.0%
    Check dated 2026-04-17T02:16:17.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    On 2026-03-30, Contacts/Locations and Study Status were added to the record; a version from 2025-12-10 was removed.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:44.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added the latest revision entry (v3.5.0) and removed the previous revision (v3.4.3) from the study record history.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:44.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.